You are aware this board is NSRCF OTC right? There is another board for the Canada ticker. So all my posts here are in regards to OTC. Second you post post all the charts you want they mean nothing. Third as I started in previous posts but I dont think you understand is there are major pivotal catalysts that make your charts irrelevant. I know how to chart trust me. I use charts for day trades and 52 week low entires. But most people dont know what they own here with NSRCF. First off they have billons of $s in the ground and the market cap is $300 million. They just hit the pivotal moment which brings everyone closer to profit and of course why institutions buy is the dividends. They dividends alone will be huge long term and the price will reflect the speculative earnings for 10 years very soon. Now everything I said is coming to light along with the 250K volume day and in next 60 days we will have million volume days I can assure you. But invest and trade as you like. I am just stating you need to understand a bigger picture outside some silly chart.
NSRC $$

Very nice large buys coming in. Volume way above normal. Think we got big news coming shortly!! NSRCF

Volume is building nicely. See some nice dumps meaning short term weak hands are exciting with profit. We will have large news soon of mine being assembled on site. Then shortly after first scoop!! Nearing the 250K volume expected for a big move up. I suspect we will be back in the 1 million volume days in next month or so. NSRCF $$

Well the PRs state mine was behind schedule due to covid. But now everything is up and running. With no catalyst yes this would drop below $1.50. But we have catalyst coming. Also I am not sure if the company is behind the PRs but possibly they have been before. But Catalyst news is mine has arrived on site. Then next catalyst is mine is finished being built. Then next catalyst is first scoop produced. Chart means very little here in my opinion. Volume isn't enough to make a difference currently we need at least a 250,000 share day or above to make any difference. But this pre run here has happened many times in the past before the big news that brings big volume. There where profit takers today but in my opinion they will regret selling. This company has like multi billions in resource. But current volume won't support a PPS rise. NSRCF

Nice!! Good Luck!!

You exited last June? Just watching? I been buying all the way down to $1.50 and been in since it was Uranium Star. This is a long term monster. Short term gains will be good. But long term we looking at billions is product in graphite alone not including vanadium and when the company becomes flush with cash dividends and I am pretty sure other property purchases and explorations. So to side line is an interesting move for sure. NSRCF

https://themarketherald.ca/one-of-the-few-able-to-fill-the-ev-markets-graphite-supply-void-2022-07-27/?fbclid=IwAR0Nq143qwIeBSCOkspOHu-wAV87lqIYZ222Yy5mXEB37Yb8aOz2ZCD50N4

https://www.mining.com/web/graphite-deficit-starting-this-year-as-demand-for-ev-battery-anode-ingredient-exceeds-supply/?fbclid=IwAR3MOGJk1dz5NYclkUq3_utuywAu9nzIki4nsadYhkmDehGutvh6bc-7SyA

These two articles below is what has fueled the buying past few days. But we also have news coming very soon about the mine arriving on site. So we should see some very high volume days here soon. I would bet it pushes us back into the $4 range again. NSRCF $$
https://www.mining.com/web/graphite-deficit-starting-this-year-as-demand-for-ev-battery-anode-ingredient-exceeds-supply/?fbclid=IwAR3MOGJk1dz5NYclkUq3_utuywAu9nzIki4nsadYhkmDehGutvh6bc-7SyA

https://themarketherald.ca/one-of-the-few-able-to-fill-the-ev-markets-graphite-supply-void-2022-07-27/?fbclid=IwAR0Nq143qwIeBSCOkspOHu-wAV87lqIYZ222Yy5mXEB37Yb8aOz2ZCD50N4

Short term stimulus here is 10Q coming in a few days and no more dilution. Bitcoin mining is currently only about 1/6 of the business assets so not the main driver in what happens here even though it is for sure something good. NILE

LOL wow even before the 10Q is posted they making bold statements. To funny. NILE

Think they said it would be out by the 23rd or maybe it was the 25th but will be soon regardless. NILE

Yeah I didn't get any 80s either but got some 1.90's man what a deal at these prices!! NSRCF

They are alluded to it being 400 million OS+. I suspected between 425-450 million OS when the 10Q drops. But signs are looking good and we have some major catalyst on the way!! NILE

Expecting nice move up. I know I am buying today! NILE

We on for a move up!! Plus they going to be buying back shares after the 25th! I am personally going in heavy right hear and doubling up. NILE

Would be wonderful to reload here at 1.98 someone is selling so we just may get there! NSRCF

That is why I load on every big dip. I loaded large at $1.18 and some at $1.20. LCTX

Umm that can not be accurate in my opinion. I believe the 10K will be an accurate amount of shares. If that is the OS then expect many more months of dilution. We should be near 400 million shares give or take. NILE

First it was opinions on price requirements. Which was answered but not accepted. Then there was opinions on reverse split. Which was answered but not accepted. Then there opinions on 150% whatevers. Which was already answered but not accepted. It is robotic in nature, Everyone has opinions and hey you know how that goes. Certain questions have been already answered without opinions and hypotheticals. When it comes to calculations now that is a different story as there are many factors. Man if I dumped every IPO that dropped after I bought I would have lost out on some huge money. I am sure you can reach out to the company and ask why. I am pretty sure you will get the same answer you where already given as there really is only one answer that was already handed out. But for some reason that answer isn't working because opinions override reality. NILE

Well I suppose that is a question only you can answer. I can't speak for any one other then me the one. NILE

So we discussing hypotheticals? You aren't even invested here? LOL. Ok well I am done speaking on all these subjects. If you where invested it would be a different story. But I dont understand all the posts and stuff truthfully if you sold and you have left this in the past. What is the purpose? Not like anything is being exposed of any significance. I personally move on when I sell a stock kinda like I do with girlfriends. Onto the next lovely one. NILE

You can add the volume which on my calculations is around 627 million then add the PPS from the 12th till now. Add all the days which it has been 15 trading days and divide that by by PPS total . So $7.40 divided by 15 is average price of .493 and 20% of 627 is is 125.4 million shares. Then times 125.4 by .49 you come up with $61.44 million dollars. Add that to the previous amount already raised as of April 1tth. How ever I think dilution is higher at like 25% personally but we will see. NILE

The damn 10Q was accountable top to April 11th. Why dont you go back and look at what the volume and the price was on April 12th and the week of April 12th it will answer a lot of your questions on average PPS and what is left.

If there was enough demand volume to sustain at a higher price we would already be there. They are getting this out of the way we just have to deal with it. All there is to it nothing else to be said. NILE

I am feeling exactly the same then we have the 10Q within a couple of weeks and we will know much better where we are with the OS, Cash on books and other added values we didn't see in the 10K. NILE

Well how much longer do you think we have and how much money do you think they have brought in? NILE

We are literally nearly done with dilution could be tomorrow or day after. Ride it out or not that is really the only decision here. Plenty of stocks out there to play. Not sure how letting the PPS rise is going to help them get $220 million? Nothing wrong with building an empire in my opinion. The goal wasn't to have $500K in assets it is to have a billion in assets. I suppose if one got it for short term gains then they are in the wrong stock. What brought people in is volume short interest is less simple because volume is less it isn't rocket science. When volume was 140+ million it is obviously going to be shorted more. at 20 million they are limited to what they can short. But the 10Q will be a major catalyst and it will for sure bring back the 100+ million volume. So love it or leave it pretty much. NILE

All truth hurts I know. All good keep on keeping on!! NILE

Cool sounds like you got better investments to attend to. Good Luck!! NILE

Will your stock pop on an approval? Probably but will the market cap ever reach anything substantial? No it won't with that drug as it has a very small limited market. So if you are looking for short penny pop you are in the right stock. I personally have no interest in that bio nor does it pop out and say wow to me. I play penny bios sometimes for short term gains but in general my penny stocks are above $1. As Nile was when it caught my eyes. Never the less NILE is not a biotech company they are invested in one so the subject doesn't mean much to me as ALZN is small compare to NILEs other investments. NILE

It isn't about Phase trials when I invest in Biotechs. It is about how much money the product can bring to market throughout its lifespan of patent. I dont invest in Bios that have drugs for rare conditions. As the amount produced from a rare condition is minuscule. But anyway the subject was about NILE not some other random Biotech company in phase 3 there are so many biotechs in phase 3s it is silly. I know of many better deals in bios who have much better drugs I am invested in a few. NILE

5.8 million Americans were living with Alzheimer's disease. Younger people may get Alzheimer's disease, but it is less common. The number of people living with the disease doubles every 5 years beyond age 65. So you are telling me a drug that services rare skin conditions has more potential then a Alzheimer's drug? May I add the same drug they are using for Alzheimer's also is being tested for simultaneously Bi-Polar disorder, Bipolar disorder (manic-depressive illness) is a neurobiological brain disorder that affects approximately 2.3 million Americans today, or almost 1 percent of the population. Depression, Depression is a common illness worldwide, with an estimated 3.8% of the population affected, including 5.0% among adults and 5.7% among adults older than 60 years . Approximately 280 million people in the world have depression. And Post Traumatic Stress Disorder, Estimated 310 million people suffer from PTSD. So you are telling me a drug that services a rare skin condition has more potential then AZLNs AL001? I find that interesting. But anyway thanks for your opinion very valuable!! NILE
Below is ALZN website
https://alzamend.com/pipeline/

LOL interesting investment!!

LOL!! I see.

LOL wow thanks for the great insight!! NILE

Well I believe you can message Todd or the CEO and make some recommendations how to make NILE a winner!! NILE

Well I addressed it multiple times however you may not be able to understand what I am writing. So to put it in simple terms as I stated before investing in any stock is risky. However betting in early stage biotech is even riskier. The point of Phase1, phase2 and phase3 trials is to mainly establish efficacy. If efficacy is well proven it leads to great things for a company. So that being said all I know is the drugs potential in the market which you can see on ALZN website. Which I actually provided a link just last night on another message. Never the less NILE is investing very early on. So far the decision is paying off as we are about to step into phase 2 on that particular drug as ALZN has 2 major products in the pipeline of testing. One is behind the other. Never the less ALZN needs to raise capitol in order to do the scientific research. Which phase trials are expensive and go on for long periods of time. As stated in last nights messages it was established it will be a couple years before one of the drugs in the pipeline will even be close to approval. Because trials dont happen overnight. So the bet is risky we are funding an early stage bio company. I know you want instant gratification from investments which as I stated before is not logical at all. It is funny you have never seen an investor pay over market value which tells me you have probably never invested in an early stage biotech company. Which is all good we live and we learn. But however if you know what a marketing partner is? Not sure if you do. It is an existing large cap biotech company that already has drugs in the pipeline and already has access to distribute the drug. Not just distribute it but market it and educate doctors on what it is so the doctors will prescribe it. Doctors are paid incentives in the form of all sorts of gifts to prescribe a new drug and in general a doctor would not know what a new drug is if sales teams weren't teaching them what it is so they can prescribe it. So plenty of marketing partners pay well above market price for biotech companies when they come in as a partner. Rarely does a Biotech get a market partner before phase trials. Meaning the phase trials efficacy will give confidence to a marketing partner and of course shareholders. So for instance if ALZN phase 2 trials come in good then it is a very strong chance they will get a marketing partner to continue to fund them through phase 3 trials, approval and of course bringing the drug to market. ALZN has no profit has no cash flow because they are an early stage Biotech. So if they want to bring the drug to market they have to raise investors who see the drugs potential. So yes NILE is betting early stage on ALZN as I stated in a prior message is very risky. But NILE hired consultants and felt it was worth the risk. So the more cash they have the easier it is for them to complete phase 2. If you look at the 10K they mention when ALZN makes certain MILESTONES now I emphasize that word as it is important. Because as stated above those milestones are what give investors confidence and marketing partners confidence. So as I stated in previous messages if Phase 2 comes in well then there is a very strong chance we get a marketing partner to pay for the completing studies and bringing it to market. I also mentions how Biotechs ebb and flow and the catalyst that move biotech. Now if you dont understand any of the words in these sentences please just let me know which words you need help with and I can further elaborate. So we as NILE are providing ALZN large amount of capital with a bet that ALZN pipeline drugs will make it approval. Because if they do it is billions upon billions of dollars for these drugs once they reach market. So what I am getting at is even paying $5 for a stock trading at $1 is to help them raise the capital needed to make it through trials. Again it isn't a scam but it is risky. Which is why marketing partners get in after some trials because they want to make a more educated bet. So it is common in biotech for an investor or marketing partner to pay way above the trading PPS. to help fund the company because when the drug gets approved they will make way more than they invested over the drugs life of sales. Does that help? NILE

Well yes of course but reaching market is not the only catalyst. As I stated if phase 2 has great efficacy it will make PPS rise and it will most likely attract a large Pharma marketing partner which is also a huge catalyst for pharmas as the marketing partner will fund it to approval. Then of course if phase 3 efficacy is proper then it will be another driver then of course the approval is the huge driver. That is why there is an ebb and flow with Pharmas. Because the process is literally they get shorted between each catalyst and of course their are profit takers between each catalyst as well as short investors when the volume comes in from each catalyst. NILE

As you can see in the link below the AL001 has multiple applications.
https://alzamend.com/pipeline/
Alzheimer’s disease
Bi-Polar disorder
Depression
Post Traumatic Stress Disorder (PTSD)

The there is the other one and hasn't made phase 1 yet. AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient’s immunological system to combat Alzheimer’s.

The mix is unique. a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate NILE